Tuberculosis Testing for NTM Patients

Trial Objective

Tuberculosis Testing for NTM PatientsThe purpose of this study is to determine if a new blood test known as the VIDAS Interferon Gamma Release Assay (VIDAS TB-IGRA) is effective at diagnosing tuberculosis (TB) in people with nontuberculous mycobacteria (NTM). The study will evaluate whether nontuberculous mycobacteria interfere with the positive Mycobacterium tuberculosis diagnosis. Researchers are comparing VIDAS TB-IGRA with other diagnostic tests known to accurately detect latent tuberculosis in NTM patients. It is important to rule out a TB infection when treating NTM.


Active Clinical Trials Currently Recruiting

Who Can Participate

People with suspected NTM infection based on clinical symptoms and/or early diagnostic evidence may be eligible for this study.

Age: 18+    Gender: Any Gender

Estimated Time Commitment

Up to 2 clinic visits

Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Michael White

Michael White

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors


Principal Investigators


Request More Information

Complete this form to learn more about this study and see if you qualify.